MRD status across compartments at the end of cycle 30 and monitoring of resistance mutations. (A) Head-to-head comparison of uMRD across compartments at the end of cycle 30. (B) Swimmer plot monitoring resistance mutations in ctDNA. Bars depict the duration of treatment for each patient up to cycle 31, representing the time until the final response assessment. Patients undergoing maintenance therapy are indicated by black arrows. FC, flow cytometry; FUP, follow-up; UPN, unique patient number.